Sponsored Article: Improving Alzheimer's Disease Diagnosis Using CSF or PET Biomarkers - MedicalExpo e-Magazine

As current therapies for Alzheimer’s disease focus on preventing cognitive decline and treating symptoms, rather than a cure, it is critical to determine amyloid pathology early in the Alzheimer’s disease spectrum at the MCI stage.

As current therapies for Alzheimers disease focus on preventing cognitive decline and treating symptoms, rather than a cure, it is critical to determine amyloid pathology early in the Alzheimers dise… [+6041 chars]

full article...